Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 1
Submit an article Journal homepage
275
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

A unique acute myeloid leukemia patient with cryptic NUP98-NSD1 gene and ASXL1 mutation

Jiangxia CuiJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, P.R. China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, P.R. China;Shanxi Academy of Medical Science, Shanxi Da Yi Hospital, Taiyuan, P.R. China
,
Jundan XieJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, P.R. China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, P.R. China
,
Lili QinJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, P.R. China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, P.R. China
,
Suning ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, P.R. China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, P.R. China
,
Yun ZhaoCyrus Tang Hematology Center, Soochow University, Suzhou, P.R. ChinaCorrespondence[email protected] [email protected]
&
Deipei WuJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, P.R. China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, P.R. China
Pages 196-198 | Received 13 Jan 2015, Accepted 29 Mar 2015, Published online: 10 Apr 2015

References

  • Huang N, vom BE, Garnier JM, et al. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. EMBO J 1998;17:3398–3412.
  • Petit A, Radford I, Waill MC, et al. NUP98-NSD1fusion by insertion in acute myeloblastic leukemia. Cancer Genet Cytogenet 2008;180:43–46.
  • Jaju RJ, Haas OA, Neat M, et al. A new recurrent translocation, t (5; 11) (q35; p15.5), associated with del (5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG). Blood 1999;94:773–780.
  • Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood 2011;118:3645–3656.
  • Thol F, Kölking B, Hollink IH, et al. Analysis of NUP98/ NSD1 translocations in adult AML and MDS patients. Leukemia 2013;27:750–754.
  • Wang GG, Cai L, Pasillas MP, et al. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 2007;9:804–812.
  • Thanasopoulou A, Tzankov A, Schwaller J. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction. Haematologica 2014;99:1465–1471.
  • Gelsi-Boyer V, Brecqueville M, Devillier R, et al. Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol Oncol 2012;5:12.
  • Abdel-Wahab O, Adli M, LaFave LM, et al. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Cancer Cell 2012;22:180–193.
  • Patel JP, Gönen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012;366:1079–1089.
  • Abdel-Wahab O, Gao J, Adli M, et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J Exp Med 2013;210:2641–2659.
  • Yan L, Ping N, Zhu M, et al. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica 2012;97:1708–1712.
  • Ostronoff F, Othus M, Gerbing RB, et al. NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report. Blood 2014;124: 2400–2407.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.